Arrowhead Pharmaceuticals stock experiences MACD Death Cross and RSI Overbought signals.

Arrowhead Pharmaceuticals's 15-minute chart has recently exhibited a MACD Death Cross and RSI Overbought reading of 12/03/2025 at 14:45. This suggests that the stock price is likely to experience further decline, as it has risen too rapidly and exceeds the level of fundamental support.